ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FUM Futura Medical Plc

35.65
0.15 (0.42%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.15 0.42% 35.65 35.40 35.90 36.50 34.05 36.50 425,707 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -5.85M -0.0194 -18.25 106.45M

Futura Medical PLC Block Listing Update (4913X)

24/11/2017 1:08pm

UK Regulatory


Futura Medical (LSE:FUM)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Futura Medical Charts.

TIDMFUM

RNS Number : 4913X

Futura Medical PLC

24 November 2017

 
    24 November 2017 
 

Futura Medical plc

("Futura" or "the Company")

Block Listing Update

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology makes the following update on its block listing, pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies. All figures relate to options over ordinary shares of 0.2 pence each.

The table below provides further detail.

 
  Name of company:                                    Futura Medical plc 
  Name of scheme:                                     Unapproved Share Option Scheme ("USOS") 
 
                                                       EMI Share Option Scheme ("EMI") 
  Period of return:                                   From:           25 May 2017 
                                                      To:             24 November 2017 
  Number and class of securities not issued under 
   the scheme(s) at start of period                   USOS:           2,446,110 
   EMI:                                                               3,021,390 
   Total:                                                             5,467,500 
  Number of securities issued under the scheme(s)     USOS:           - 
  during the period 
 
  Number of securities lapsed under the scheme(s) 
  during the period 
                                                      EMI:            - 
 
    USOS:                                                              50,000 
    EMI:                                                               350,000 
  Balance under the scheme(s) of securities not 
   yet issued at the end of the period                USOS:           2,396,110 
   EMI:                                                               2,671,390 
   Total:                                                             5,067,500 
  Number and class of securities originally           USOS:           814,424 on 25 May 2011, 1,202,280 on 8 October 
  admitted and the date of admission                                  2013, 1,466,208 on 25 May 2017 
   USOS Total:                                                        3,482,912 
 
                                                      EMI:            1,520,576 on 25 May 2011, 1,467,720 on 8 October 
                                                                      2013 
                                                                      1,893,792 on 25 May 2017 
   EMI Total:                                                         4,882,088 
 
   Total:                                                             8,365,000 
  Name of contact:                                    Derek Martin, Chief Financial Officer 
  Telephone number of contact:                        +44 (0) 1483 685 670 
 

For further information please contact:

 
  Futura Medical plc 
  James Barder, Chief Executive                   Tel: +44 (0) 1483 
                                                            685 670 
  Email to: james.barder@futuramedical.com    www.futuramedical.com 
   N+1 Singer (Nominated Adviser 
    and Broker) 
  Aubrey Powell / Liz Yong                      Tel:+44 (0) 20 7496 
   Corporate Finance                                           3000 
  For media enquiries please 
   contact: 
  Buchanan 
  Mark Court / Sophie Cowles                   Tel: +44 (0) 20 7466 
   / Stephanie Watson                                          5000 
 

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCPGGWUGUPMGWC

(END) Dow Jones Newswires

November 24, 2017 08:08 ET (13:08 GMT)

1 Year Futura Medical Chart

1 Year Futura Medical Chart

1 Month Futura Medical Chart

1 Month Futura Medical Chart

Your Recent History

Delayed Upgrade Clock